相似文献
1
Systems biology of polycystic kidney disease: a critical review.
Wiley Interdiscip Rev Syst Biol Med. 2015 Jan-Feb;7(1):39-52. doi: 10.1002/wsbm.1289. Epub 2015 Feb 2.
2
The Gretchen question in autosomal-dominant polycystic kidney disease research.
J Mol Med (Berl). 2011 Mar;89(3):247-50. doi: 10.1007/s00109-011-0734-6.
3
Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Feb;35(2):93-9. doi: 10.3969/j.issn.1672-7347.2010.02.001.
4
A polycystin-centric view of cyst formation and disease: the polycystins revisited.
Kidney Int. 2015 Oct;88(4):699-710. doi: 10.1038/ki.2015.207. Epub 2015 Jul 22.
5
Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.
EBioMedicine. 2016 Jan 26;5:183-92. doi: 10.1016/j.ebiom.2016.01.027. eCollection 2016 Mar.
6
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.
J Clin Invest. 2014 Jun;124(6):2315-24. doi: 10.1172/JCI72272. Epub 2014 Jun 2.
7
Polycystic kidney disease: Polycystin-1 and polycystin-2--it's complicated.
Nat Rev Nephrol. 2013 May;9(5):249-50. doi: 10.1038/nrneph.2013.73. Epub 2013 Apr 9.
8
ARPKD and ADPKD: first cousins or more distant relatives?
J Am Soc Nephrol. 2008 Mar;19(3):416-8. doi: 10.1681/ASN.2008010033. Epub 2008 Feb 13.
9
Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
Am J Physiol Renal Physiol. 2023 Dec 1;325(6):F857-F869. doi: 10.1152/ajprenal.00056.2023. Epub 2023 Oct 12.
10
An ever-expanding story of cyst formation.
Cell Tissue Res. 2000 Jun;300(3):361-71. doi: 10.1007/s004410000215.
引用本文的文献
1
Mechanisms of Cyst Development in Polycystic Kidney Disease.
Adv Kidney Dis Health. 2023 May;30(3):209-219. doi: 10.1053/j.akdh.2023.03.001.
2
Predicting Progression of Autosomal Dominant Polycystic Kidney Disease by Changes in the Telomeric Epigenome.
Cells. 2022 Oct 20;11(20):3300. doi: 10.3390/cells11203300.
3
Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.
Int J Mol Sci. 2021 Jun 26;22(13):6885. doi: 10.3390/ijms22136885.
4
The tissue proteome in the multi-omic landscape of kidney disease.
Nat Rev Nephrol. 2021 Mar;17(3):205-219. doi: 10.1038/s41581-020-00348-5. Epub 2020 Oct 7.
5
Pathway identification through transcriptome analysis.
Cell Signal. 2020 Oct;74:109701. doi: 10.1016/j.cellsig.2020.109701. Epub 2020 Jul 7.
6
Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases.
Metabolites. 2019 Feb 14;9(2):34. doi: 10.3390/metabo9020034.
7
Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease.
Science. 2018 May 18;360(6390):758-763. doi: 10.1126/science.aar2131. Epub 2018 Apr 5.
8
A Report of the 24th Annual Congress on Women's Health-Workshop on Transforming Women's Health: From Research to Practice.
J Womens Health (Larchmt). 2018 Jan;27(1):115-120. doi: 10.1089/jwh.2017.29016.orwh.
9
Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
J Cell Mol Med. 2017 Aug;21(8):1619-1635. doi: 10.1111/jcmm.13091. Epub 2017 Feb 28.
10
Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD.
Hum Genomics. 2016 Nov 21;10(1):37. doi: 10.1186/s40246-016-0095-x.
本文引用的文献
1
The robustness and evolvability of transcription factor binding sites.
Science. 2014 Feb 21;343(6173):875-7. doi: 10.1126/science.1249046.
2
Scientific method: statistical errors.
Nature. 2014 Feb 13;506(7487):150-2. doi: 10.1038/506150a.
3
Expanding horizons: ciliary proteins reach beyond cilia.
Annu Rev Genet. 2013;47:353-76. doi: 10.1146/annurev-genet-111212-133243. Epub 2013 Sep 6.
4
Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease.
Nat Genet. 2013 Sep;45(9):1004-12. doi: 10.1038/ng.2715. Epub 2013 Jul 28.
5
Polycystic kidney disease: Polycystin-1 and polycystin-2--it's complicated.
Nat Rev Nephrol. 2013 May;9(5):249-50. doi: 10.1038/nrneph.2013.73. Epub 2013 Apr 9.
6
Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.
Nephrol Dial Transplant. 2013 Aug;28(8):2045-58. doi: 10.1093/ndt/gft014. Epub 2013 Mar 29.
7
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.
Nat Med. 2013 Apr;19(4):488-93. doi: 10.1038/nm.3092. Epub 2013 Mar 24.
8
Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.
PLoS One. 2013;8(1):e53780. doi: 10.1371/journal.pone.0053780. Epub 2013 Jan 10.
9
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
PLoS One. 2013;8(1):e53016. doi: 10.1371/journal.pone.0053016. Epub 2013 Jan 10.
10
Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany.
Nephrol Dial Transplant. 2013 Jun;28(6):1472-87. doi: 10.1093/ndt/gfs551. Epub 2013 Jan 8.
Zotero 插件